News

We send the latest information from SMC Laboratories.

2023.02.08

PRODUCTS AND SERVICE

Introduction of positive control drug for kidney fibrosis mouse model

Today, we would like to introduce an established positive control – an ALK5 inhibitor – for our Un…

READ MORE

2023.02.01

PRODUCTS AND SERVICE

Introduction of our experiences in histopathological analyses for IPF

Today, we present some new histopathological data from our bleomycin-induced pulmonary fibrosis model, which i…

READ MORE

2022.12.05

PRODUCTS AND SERVICE

Introduction of STAM™ model for pre-clinical studies for liver cancer

Today, we give you a brief introduction to our proprietary NASH-HCC model (STAM™ model). The STAM™…

READ MORE

2022.11.16

PRODUCTS AND SERVICE

Introducing our new skin disease model: Imiquimod (IMQ)-induced psoriasis model

We are pleased to announce that we have expanded our preclinical model lineup by including the “Imiquimo…

READ MORE

2022.10.26

PRODUCTS AND SERVICE

Introduction of our Primary sclerosing cholangitis (PSC) mice model

Today, I would like to give you a brief introduction into primary sclerosing cholangitis (PSC), as well as our…

READ MORE

2022.09.07

PRODUCTS AND SERVICE

Introducing our Idiopathic Pulmonary Fibrosis (IPF) mouse model

The outbreak of COVID-19 causes a lot of complications and long-term harm to the patient, especially severe pu…

READ MORE

2022.06.10

PRODUCTS AND SERVICE

Potential NASH biomarker in NASH-HCC model

We would like to introduce the data for a serological marker from our NASH model (STAM™ model). Hepatoce…

READ MORE

2022.05.10

PRODUCTS AND SERVICE

Introducing our new model: DDC-induced liver injury model

We introduce the 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced liver injury model*, a well-known mod…

READ MORE

2021.07.01

PRODUCTS AND SERVICE

Introducing our new model: Liver Orthotopic Xenograft mouse model

We’re getting in touch today with an announcement regarding the addition of the Liver Orthotopic Xenogra…

READ MORE

2021.04.26

PRODUCTS AND SERVICE

Pre-clinical studies for cirrhosis: Carbon tetrachloride (CCl4)-induced liver fibrosis

The CCl4-induced liver fibrosis model is a model that forms bridging fibrosis around the portal vein region. W…

READ MORE

Page 3 of 4First1234Last